Epidemiological Study to Describe Non-small-cell Lung Carcinoma (NSCLC) Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA
This trial is active, not recruiting.
|Condition||nsclc patient characteristics|
|Start date||April 2011|
|End date||March 2013|
|Trial size||54 participants|
|Trial identifier||NCT01330862, NIS-MENA-SA-IRS-2010/01|
The study is to provide accurate, reliable information on NSCLC clinical management across MENA (Middle East North Africa) countries in order to detect unmet medical needs of this disease, it is a purely observational study; therefore patients are not assigned to a particular therapeutic strategy beforehand by a protocol. Treatment will be according to current clinical practice.
|United States||No locations recruiting|
|Other countries||No locations recruiting|
|Qassim, Saudi Arabia||Research Site||no longer recruiting|
|Riyadh, Saudi Arabia||Research Site||no longer recruiting|
|Dammam, Saudi Arabia||Research Site||no longer recruiting|
|Jeddah, Saudi Arabia||Research Site||no longer recruiting|
Male or female participants at least 18 years old.
Inclusion Criteria: - Confirmed NSCLC diagnosis (e.g. bronchoscope or FNAB), all stages, men and women, attending the responsible department of treating this type of patients for the first time between April 1st 2011 and March 31 2012, for PRO sub-sample: ability to read and write since they will be asked to participate in the PRO part of the study. Selection will not be based on the disease stage of each patient, in order to avoid a selection bias Exclusion Criteria: - According to the study design there will not be any exclusion criteria in order to provide a high validity and to obtain the most accurate real daily practice information.
|Official title||Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA|
|Principal investigator||Dr. Ahmed Abdulwarith|
Call for more information